BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33046212)

  • 1. Cytotoxic T cells swarm by homotypic chemokine signalling.
    Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
    Elife; 2020 Oct; 9():. PubMed ID: 33046212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
    Berencsi K; Rani P; Zhang T; Gross L; Mastrangelo M; Meropol NJ; Herlyn D; Somasundaram R
    J Transl Med; 2011 Mar; 9():33. PubMed ID: 21450101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
    Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
    J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization.
    Ariotti S; Beltman JB; Borsje R; Hoekstra ME; Halford WP; Haanen JB; de Boer RJ; Schumacher TN
    J Immunol; 2015 Dec; 195(11):5285-95. PubMed ID: 26525288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.
    Shalapour S; Font-Burgada J; Di Caro G; Zhong Z; Sanchez-Lopez E; Dhar D; Willimsky G; Ammirante M; Strasner A; Hansel DE; Jamieson C; Kane CJ; Klatte T; Birner P; Kenner L; Karin M
    Nature; 2015 May; 521(7550):94-8. PubMed ID: 25924065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
    Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
    Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.
    Ochsenbein AF; Sierro S; Odermatt B; Pericin M; Karrer U; Hermans J; Hemmi S; Hengartner H; Zinkernagel RM
    Nature; 2001 Jun; 411(6841):1058-64. PubMed ID: 11429607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.
    Sharma RK; Chheda ZS; Jala VR; Haribabu B
    Expert Rev Vaccines; 2015 Apr; 14(4):537-49. PubMed ID: 25482400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.
    Trifilo MJ; Bergmann CC; Kuziel WA; Lane TE
    J Virol; 2003 Apr; 77(7):4004-14. PubMed ID: 12634360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH3T3 Directs Memory-Fated CTL Programming and Represses High Expression of PD-1 on Antitumor CTLs.
    Qin Y; Lee Y; Seo J; Kim T; Shin JH; Park SH
    Front Immunol; 2019; 10():761. PubMed ID: 31031760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.
    Boissonnas A; Fetler L; Zeelenberg IS; Hugues S; Amigorena S
    J Exp Med; 2007 Feb; 204(2):345-56. PubMed ID: 17261634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
    Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
    BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data.
    Beck RJ; Bijker DI; Beltman JB
    PLoS Comput Biol; 2020 Jul; 16(7):e1007972. PubMed ID: 32658891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and biological significance of CTL avidity.
    Snyder JT; Alexander-Miller MA; Berzofskyl JA; Belyakov IM
    Curr HIV Res; 2003 Jul; 1(3):287-94. PubMed ID: 15046253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.
    McAlpine SM; Issekutz TB; Marshall JS
    FASEB J; 2012 Mar; 26(3):1280-9. PubMed ID: 22125314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells.
    Li JH; Rosen D; Sondel P; Berke G
    Immunology; 2002 Mar; 105(3):267-77. PubMed ID: 11918688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4
    Borst J; Ahrends T; Bąbała N; Melief CJM; Kastenmüller W
    Nat Rev Immunol; 2018 Oct; 18(10):635-647. PubMed ID: 30057419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.